发明名称 |
Extracellular camp-dependent protein kinase in diagnosis, prognosis and treatment of cancer |
摘要 |
The present invention provides methods for diagnosing and prognosticating cancer in a patient as well as a method of determining whether or not a diagnosed breast cancer is hormone-dependent or hormone-independent. The methods comprise assaying a sample from a patient for ECPKA (ECPKA). Also provided by the present invention are a method that is potentially useful in treating cancer in a patient by reducing the level of ECPKA by down-regulation, such as by delivering the RII beta subunit of PKA-II to target cancer cells, and a method that is potentially useful in treating cancer in a patient by inhibiting the expression of both of the wild-type type I and type II isozymes of PKA, such as by delivering a mutant of the RI alpha subunit of PKA to target cancer cells. |
申请公布号 |
AU5618700(A) |
申请公布日期 |
2001.01.09 |
申请号 |
AU20000056187 |
申请日期 |
2000.06.16 |
申请人 |
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY |
发明人 |
YOON S. CHO-CHUNG |
分类号 |
A61K38/45;A61K48/00;G01N33/573;G01N33/574 |
主分类号 |
A61K38/45 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|